Burgundy Asset Management’s Integra LifeSciences IART Stock Holding History

Burgundy Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,433	Closed	-$237K	–	105
2023 Q4	$237K	Buy	+5,433	New	+$214K	﹤0.01%	104
2023 Q3	–	Sell	-5,206	Closed	-$214K	–	104
2023 Q2	$214K	Hold	5,206	–	–	﹤0.01%	106
2023 Q1	$299K	Hold	5,206	–	–	﹤0.01%	103
2022 Q4	$292K	Hold	5,206	–	–	﹤0.01%	106
2022 Q3	$221K	Hold	5,206	–	–	﹤0.01%	110
2022 Q2	$281K	Hold	5,206	–	–	﹤0.01%	110
2022 Q1	$335K	Hold	5,206	–	–	﹤0.01%	112
2021 Q4	$349K	Hold	5,206	–	–	﹤0.01%	109
2021 Q3	$357K	Hold	5,206	–	–	﹤0.01%	111
2021 Q2	$355K	Hold	5,206	–	–	﹤0.01%	113
2021 Q1	$360K	Hold	5,206	–	–	﹤0.01%	109
2020 Q4	$338K	Hold	5,206	–	–	﹤0.01%	106
2020 Q3	$246K	Hold	5,206	–	–	﹤0.01%	102
2020 Q2	$245K	Hold	5,206	–	–	﹤0.01%	104
2020 Q1	$233K	Buy	+5,206	New	+$273K	﹤0.01%	99

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Burgundy Asset Management's IART Position: Q1 2024 in Review

Burgundy Asset Management sold out of Integra LifeSciences (IART) in Q1 2024, closing a stake of 5,433 shares — an estimated $237K sold.

Burgundy Asset Management first reported a position in IART in Q1 2020 and held it in 15 quarters. The position peaked at $360K in Q1 2021. 281 funds tracked by Wall St. Rank hold IART as of Q1 2024.

Burgundy Asset Management reported no remaining Integra LifeSciences position as of Q1 2024 after selling out during the quarter.
Burgundy Asset Management sold 5,433 Integra LifeSciences shares in Q1 2024, an estimated $237K.
Burgundy Asset Management first reported a position in Integra LifeSciences in Q1 2020 and held it in 15 quarters.
Burgundy Asset Management's Integra LifeSciences position peaked at $360K in Q1 2021.
281 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2024.

Based on Burgundy Asset Management's 13F filing for Q1 2024, filed 13 May 2024.